Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA

Numerous companies merit attention at present due to recent developments. This feature offers a brief overview of five such companies.

Creative Medical Technology Holdings Inc. (NASDAQ: CELZ): Renowned for its pioneering advancements in biotechnology, Creative Medical Technology Holdings achieved a significant milestone on March 7. The company unveiled a groundbreaking initiative aimed at addressing Type 1 Diabetes Mellitus (T1D). In a press release, Creative Medical Technology Holdings announced that it had received FDA authorization for an expanded-access therapy featuring CELZ 201. This innovative cell-based program is designed to manage abnormal glucose tolerance and preempt the onset of T1D in high-risk individuals. Notably, CELZ 201 represents a historic breakthrough in medical science, as it stands as the first product capable of preventing T1D altogether. Emphasizing a personalized approach, this revolutionary therapy is tailored to address the needs of each patient on an individual basis.

Dyadic International Inc. (NASDAQ: DYAI) The company specializes in advanced microbial platforms for protein development and bioproduction to address clinical needs. In February 2024, it was revealed that Dyadic extended its partnership with the Israel Institute for Biological Research (IIBR) and its affiliate, Life Sciences Research Israel (LSRI), to develop solutions for emerging diseases and Dyadic garnered attention for its partnership with Cygnus Technologies, a division of MaravaiLifeSciences (NASDAQ: MRVI).In March 2024, Dyadic is scheduled to take part in three significant events: BIO-Europe Spring event in Barcelona, Spain from March 18 to March 24, Future Food Tech: Innovation and Investment from Farm to Fork, happening from March 21 to March 22 at the San Francisco Marriott Marquis in California, and the Vaccine Innovation Forum World on March 22 in Shanghai, China.

Grom Social Enterprises Inc. (NASDAQ: GROM): Positioned at the intersection of media, entertainment, and technology, Grom Social Enterprises is renowned for its web filtering technology, family-friendly content, and social media safety solutions designed for children. On March 7, the company unveiled a significant development: the signing of a non-binding letter of intent for the complete acquisition of Arctic7 Inc., a leading service provider in the gaming industry. This strategic move is poised to grant Grom Social Enterprises access to the thriving and rapidly expanding gaming sector. Furthermore, it presents an opportunity for the company to leverage gaming technology to enhance its core services. With the global gaming industry currently valued at $185 billion and showing signs of continued growth, this acquisition aligns with Grom Social Enterprises' strategic objectives. Moreover, the acquisition of Epic Games byThe Walt Disney Company (NYSE: DIS)serves as a testament to the potential synergy between content and gaming entities.

Catheter Precision Inc. (NYSE American: VTAK):The company has advanced significantly in the medical technology sector with its innovative offerings. Catheter Precision Inc.'s standout product, VIVO, has revolutionized cardiac procedures. HC21, the company's distributor in the United Kingdom, has conducted 165 procedures since September 2021, resulting in $1500 in revenues per procedure for Catheter Precision Inc. with a gross margin of 90%.Catheter Precision, Inc. (NYSE American: VTAK) is approaching its 200-day moving average (DMA) and a breakout point at $0.59, maintaining a consistent trading pattern above both its 20 and 50 DMAs. The convergence of multiple bullish indicators, alongside a robust upward trend, suggests that surpassing the $0.59 threshold could trigger another upward trend for the stock.

Brera Holdings PLC (NASDAQ: BREA): Pioneering as the world's first publicly traded multi-club ownership entity in soccer, Brera Holdings PLC made headlines on March 7 with an announcement regarding its executive chairman, Daniel J. McClory. Notably, McClory, a seasoned investment banking figure, acquired a majority stake in the company. This move underscores McClory's confidence in Brera Holdings' potential for robust expansion beyond its Italian roots. As per the news release, McClory acquired 4,550,000 Class A ordinary shares, boosting his total holdings to 6,850,000 Class A ordinary shares, securing a 54.5% ownership stake. Furthermore, this acquisition grants McClory 83.7% of the total votes within Brera Holdings. With extensive expertise in establishing and financing growth-oriented entities, McClory's involvement marks a significant development for Brera Holdings.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.